Judith Stangl-Kremser

6PUBLICATIONS
10CO-AUTHORS
Molecular targetsRadiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 24, 2025
Baseline Imaging Derived Factors of Response Following [225Ac]Ac-J591 Therapy in Metastatic Castration-Resistant Prostate Cancer: A Lesion Level Analysis.

Judith Stangl-Kremser, Andres Ricaurte-Fajardo, Sandra Huicochea Castellanos

|Nov 03, 2023
Prostate-Specific Membrane Antigen-Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225Ac-J591.

Scott T Tagawa, Charlene Thomas, A Oliver Sartor

|Mar 24, 2023
Response to RL-225Ac in prostate cancer: Effect of prior treatment with RL-177Lu: A systematic review of the literature.

Judith Stangl-Kremser, Andres Ricaurte-Fajardo, Kritika Subramanian

|Sep 30, 2020
Differential impact of radiation therapy after radical prostatectomy on recurrence patterns: an assessment using [68Ga]Ga-PSMA ligand PET/CT(MRI).

Bernhard Grubmüller, Victoria Jahrreiss, Nicolai Huebner

|Feb 25, 2020
The prognostic impact of tumour NSD2 expression in advanced prostate cancer.

Judith Stangl-Kremser, Ursula Lemberger, Melanie R Hassler

|Nov 21, 2019
Assessment of body composition in the advanced stage of castration-resistant prostate cancer: special focus on sarcopenia.

Judith Stangl-Kremser, Rodrigo Suarez-Ibarrola, David D' Andrea

Pageof 1